Remission in cushing disease with cabergoline [PDF]
Annals of Saudi Medicine, 2008 Raju A. Gopal +3 more
openaire +3 more sources
Armaghane Danesh Bimonthly Journal, 2019 Background & aim: The anti-inflammatory effects of cabergoline have been documented in various studies. The purpose of the present study was to evaluate the effects of cabergoline administration (as a potent D2 agonist) on clinical aspects and immune ...
E Shaftaloud +2 more
doaj
A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma
JACC: Case Reports, 2020 We present a case of spontaneous coronary artery dissection associated with cabergoline treatment for prolactinoma. A 31-year-old woman with history of hypertension and prolactinoma, treated with cabergoline, presented with chest pain.
Shinichiro Ikeda, MD +3 more
doaj
The Effect of Cabergoline on Sleep, Periodic Leg Movements in Sleep, and Early Morning Motor Function in Patients with Parkinson's Disease [PDF]
, 2003 Birgit Högl +3 more
openalex +1 more source
HKCOG guidelines: induction of ovulation [PDF]
, 2012 This guideline by The Hong Kong College of Obstetricians and Gynaecologists (HKCOG) covers the classification of ovulation disorders, treatment options of various ovulation disorders, and their associated risks ...
Lee, VCY, Li, RHW, Ng, EHY, Yeung, TWY
core
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia [PDF]
, 2003 Annamaria Colao +5 more
openalex +1 more source
Six Months of Treatment with Cabergoline Restores Sexual Potency in Hyperprolactinemic Males: An Open Longitudinal Study Monitoring Nocturnal Penile Tumescence [PDF]
, 2004 Michele De Rosa +7 more
openalex +1 more source
Colao A, Di Sarno A, Cappabianca P, et al: Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 349:2023–2033, 2003 [PDF]
, 2004 William T. Couldwell +2 more
openalex +1 more source